

StoneX Group (SNEX) is rated Buy, with 18% upside to a $67 fair value, reflecting robust profitability and synergy realization post-R.J. O'Brien acquisition. SNEX's cost structure is highly variable, supporting profitability even during quieter quarters, while client float income remains resilient without requiring high volatility. Fiscal Q4 results are anticipated to exceed consensus, leveraging CME's record volumes and ongoing cost synergies, with EPS estimates above market expectations.

StoneX Group Inc. (NASDAQ: SNEX - Get Free Report) CEO Philip Smith sold 45,000 shares of the stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $59.50, for a total transaction of $2,677,500.00. Following the sale, the chief executive officer directly owned 738,216 shares of the company's stock,

Robinhood Markets HOOD and StoneX Group SNEX operate in the financial services and brokerage industry, offering trading, execution and access to global financial markets. However, their distinct business models create different growth opportunities and risk exposures.

StoneX starts coverage of Pasqal at Buy, citing the quantum developer's strong commercial traction and approach to building systems.

SNEX's Integra deal strengthens its Colombian coffee platform and expands its physical commodities capabilities.

NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX) today announced that it has signed a definitive agreement to acquire Integra Trading S.A.S. ("Integra"), a coffee trader, exporter, and bean processor with extensive capabilities in Colombia.

What happened StoneX Group Inc. (NASDAQ: SNEX) Chief Executive Officer Philip Andrew Smith sold 56,250 shares on 2026-09-28 for about $3.69 million. The filing says he exercised 56,250 stock options at $8.9 and then sold the same number of common shares at $65.6869. It also shows 794,466 common shares before the sale and 738,216 after

NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- StoneX Markets LLC ("SXM"), a subsidiary of StoneX Group Inc. (NASDAQ: SNEX), has entered into an exclusive licensing agreement with Cotlook to launch a new suite of OTC cotton derivatives, designed to help market participants manage risk in an increasingly globalised cotton market. The first product developed under the partnership will be the Cotlook Brazil Basis Swap, a new risk management tool referencing Cotlook's internationally recognised cotton pricing benchmarks.